Innoprot is an innovative company provider of cell-based assays for High Throughput Screening, High Content Analysis and phenotypic Screening. Human and animal primary cells are also available at Innoprot.
Innoprot develops and is commercializing proprietary multiplexed cell‐based assays using fluorescent biosensors for GPCR screening. This technology, called Nomad Biosensors, allows the measurement in a single assay of the different pathways involving drug target activation, β‐Arrestin recruitment & 2nd messenger release (Ca++, cAMP or DAG). This multiplex approach increases the characterization level of your compounds, reducing time, costs and handling requirements.
In vitro disease models for Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis and Stroke are also available at Innoprot.